Waters Co. (NYSE:WAT) Shares Sold by River & Mercantile Asset Management LLP

River & Mercantile Asset Management LLP reduced its position in Waters Co. (NYSE:WATGet Rating) by 1.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,014 shares of the medical instruments supplier’s stock after selling 770 shares during the period. Waters makes up 2.6% of River & Mercantile Asset Management LLP’s investment portfolio, making the stock its largest holding. River & Mercantile Asset Management LLP’s holdings in Waters were worth $14,578,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of WAT. Asset Dedication LLC acquired a new position in Waters during the 3rd quarter valued at about $26,000. EdgeRock Capital LLC bought a new stake in Waters during the third quarter worth $27,000. Guardian Wealth Advisors LLC bought a new stake in Waters during the third quarter worth $31,000. CI Investments Inc. raised its position in Waters by 75.5% in the 3rd quarter. CI Investments Inc. now owns 165 shares of the medical instruments supplier’s stock valued at $44,000 after buying an additional 71 shares during the last quarter. Finally, Ellevest Inc. lifted its stake in Waters by 142.9% during the 3rd quarter. Ellevest Inc. now owns 170 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 100 shares in the last quarter. Institutional investors and hedge funds own 88.58% of the company’s stock.

Waters Stock Performance

NYSE WAT opened at $307.28 on Friday. The company’s 50 day moving average is $327.89 and its 200-day moving average is $316.93. Waters Co. has a 12-month low of $265.61 and a 12-month high of $369.00. The company has a quick ratio of 1.66, a current ratio of 2.24 and a debt-to-equity ratio of 3.02. The firm has a market cap of $18.11 billion, a P/E ratio of 26.15, a price-to-earnings-growth ratio of 3.58 and a beta of 0.86.

Waters (NYSE:WATGet Rating) last posted its quarterly earnings results on Wednesday, February 15th. The medical instruments supplier reported $3.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.74 by $0.10. Waters had a net margin of 23.81% and a return on equity of 175.08%. The company had revenue of $858.51 million for the quarter, compared to analyst estimates of $832.85 million. During the same quarter in the previous year, the firm posted $3.67 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Sell-side analysts predict that Waters Co. will post 12.67 earnings per share for the current year.

Analysts Set New Price Targets

WAT has been the subject of several analyst reports. Wells Fargo & Company increased their target price on shares of Waters from $320.00 to $345.00 and gave the company an “equal weight” rating in a report on Thursday, February 16th. Robert W. Baird boosted their price target on shares of Waters from $334.00 to $345.00 and gave the stock a “neutral” rating in a report on Thursday, February 16th. Deutsche Bank Aktiengesellschaft began coverage on shares of Waters in a report on Tuesday, December 13th. They set a “hold” rating and a $350.00 price target on the stock. Barclays boosted their price target on shares of Waters from $340.00 to $380.00 and gave the stock an “overweight” rating in a report on Tuesday, January 24th. Finally, Citigroup boosted their price target on shares of Waters from $325.00 to $340.00 and gave the stock a “neutral” rating in a report on Thursday, February 16th. Nine equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $354.00.

Insider Activity

In other Waters news, Director Mark P. Vergnano bought 3,185 shares of the business’s stock in a transaction that occurred on Tuesday, February 28th. The shares were bought at an average cost of $313.32 per share, with a total value of $997,924.20. Following the completion of the purchase, the director now directly owns 3,557 shares of the company’s stock, valued at $1,114,479.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.77% of the stock is owned by corporate insiders.

Waters Company Profile

(Get Rating)

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATGet Rating).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.